VanO, a new glycopeptide resistance operon in environmental Rhodococcus equi isolates

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1768-1770

  Gudeta, Dereje Dadi ^a   Moodley, Arshnee ^a   Bortolaia, Valeria ^a   Guardabassi, Luca ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; RIFAMPICIN; RNA 16S; VANCOMYCIN;

ACTINOMYCETALES INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC ORGANIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PRIORITY JOURNAL; RHODOCOCCUS EQUI; SOIL MICROFLORA; VANO GENE;

BASE SEQUENCE; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; GLYCOPEPTIDES; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; OPERON; R FACTORS; RHODOCOCCUS EQUI;

EID: 84896868453     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01880-13     Document Type: Article

References (25)

1. James RC, Pierce JG, Okano A, Xie J, Boger DL. 2012. Redesign of glycopeptide antibiotics: back to the future. ACS Chem. Biol. 7:797-804. http://dx.doi.org/10.1021/cb300007j.
2. Walsh C, Fisher S, Park IS, Prahalad M, Wu Z. 1996. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem. Biol. 3:21-28. http://dx.doi.org/10.1016/S1074-5521(96)90079-4. (Pubitemid 126682705)
3. Fines M, Perichon B, Reynolds P, Sahm DF, Courvalin P. 1999. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob. Agents Chemother. 43:2161-2164. (Pubitemid 29421194)
4. Gholizadeh Y, Courvalin P. 2000. Acquired and intrinsic glycopeptide resistance in enterococci. Int. J. Antimicrob. Agents 16:11-17. http://dx.doi.org/10.1016/S0924-8579(00)00300-9.
5. Boyd DA, Willey BM, Fawcett D, Gillani N, Mulvey MR. 2008. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob. Agents Chemother. 52:2667-2672. http://dx.doi.org/10.1128/AAC.01516-07. (Pubitemid 351915706)
6. Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F. 2010. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob. Agents Chemother. 54:4643-4647. http://dx.doi.org/10.1128/ AAC.01710-09.
7. Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, Leclercq R, Courvalin P, Cattoir V. 2011. D-Ala-D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 55:4606-4612. http://dx.doi.org/10.1128/AAC.00714-11.
8. Guardabassi L, Perichon B, van Heijenoort J, Blanot D, Courvalin P. 2005. Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil. Antimicrob. Agents Chemother. 49:4227-4233. http://dx.doi.org/10.1128/AAC. 49.10.4227-4233.2005. (Pubitemid 41400968)
9. Guardabassi L, Christensen H, Hasman H, Dalsgaard A. 2004. Members of the genera Paenibacillus and Rhodococcus harbor genes homologous to enterococcal glycopeptide resistance genes vanA and vanB. Antimicrob. Agents Chemother. 48:4915-4918. http://dx.doi.org/10.1128/AAC.48.12.4915-4918.2004. (Pubitemid 39577707)
10. Vengust M, Stæmpfli H, Prescott JF. 2002. Rhodococcus equi pleuropneumonia in an adult horse. Can. Vet. J. 43:706-708.
11. Venner M, Rödiger A, Laemmer M, Giguère S. 2012. Failure of antimicrobial therapy to accelerate spontaneous healing of subclinical pulmonary abscesses on a farm with endemic infections caused by Rhodococcus equi. Vet. J. 192:293-298. http://dx.doi.org/10.1016/j.tvjl.2011.07.004.
12. Muscatello G. 2012. Rhodococcus equi pneumonia in the foal-part 2: diagnostics, treatment and disease management. Vet. J. 192:27-33. http://dx.doi.org/10.1016/j.tvjl.2011.08.009.
13. Weinstock DM, Brown AE. 2002. Rhodococcus equi: an emerging pathogen. Clin. Infect. Dis. 34:1379-1385. http://dx.doi.org/10.1086/340259. (Pubitemid 34507948)
14. Jones M, Neale T, Say P, Horne J. 1989. Rhodococcus equi: an emerging opportunistic pathogen? Aust. N. Z. J. Med. 19:103-107. http://dx.doi.org/10. 1111/j.1445-5994.1989.tb00213.x. (Pubitemid 19216766)
15. Hsueh P, Hung C, Teng L, Yu M, Chen Y, Wang H, Luh K. 1998. Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains. Clin. Infect. Dis. 27:370-375. http://dx.doi.org/10.1086/514667. (Pubitemid 28365762)
16. Davis JR, Goodwin LA, Woyke T, Teshima H, Bruce D, Detter C, Tapia R, Han S, Han J, Pitluck S. 2012. Genome sequence of Amycolatopsis sp. strain ATCC 39116, a plant biomass-degrading actinomycete. J. Bacteriol. 194:2396-2397. http://dx.doi.org/10.1128/JB.00186-12.
17. Serina S, Radice F, Maffioli S, Donadio S, Sosio M. 2004. Glycopeptide resistance determinants from the teicoplanin producer Actinoplanes teichomyceticus. FEMS Microbiol. Lett. 240:69-74. http://dx.doi.org/10.1016/j. femsle.2004.09.017. (Pubitemid 39421792)
18. Nielsen M, Lundegaard C, Lund O, Petersen TN. 2010. CPHmodels-3.0 - remote homology modeling using structure-guided sequence profiles. Nucleic Acids Res. 38:W576-W581. http://dx.doi.org/10.1093/nar/gkq535.
19. Sekine Y, Eisaki N, Ohtsubo E. 1994. Translational control in production of transposase and in transposition of insertion sequence IS3. J. Mol. Biol. 235:1406-1420. http://dx.doi.org/10.1006/jmbi.1994.1097. (Pubitemid 24150395)
20. Sekine Y, Aihara K, Ohtsubo E. 1999. Linearization and transposition of circular molecules of insertion sequence IS 3. J. Mol. Biol. 294:21-34. http://dx.doi.org/10.1006/jmbi.1999.3181.
21. Chandler M, Fayet O. 1993. Translational frameshifting in the control of transposition in bacteria. Mol. Microbiol. 7:497-503. http://dx.doi.org/10.1111/ j.1365-2958.1993.tb01140.x. (Pubitemid 23062576)
22. Leclercq R, Derlot E, Duval J, Courvalin P. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161. http://dx.doi.org/10.1056/NEJM198807213190307.
23. Arthur M, Molinas C, Depardieu F, Courvalin P. 1993. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 175:117-127. (Pubitemid 23016657)
24. Quintiliani R, Courvalin P. 1996. Characterization of Tn 1547, a composite transposon flanked by the IS 16 and IS 256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene 172: 1-8. http://dx.doi.org/10.1016/0378-1119(96)00110-2. (Pubitemid 26175756)
25. Reynolds PE, Depardieu F, Dutka-Malen S, Arthur M, Courvalin P. 1994. Glycopeptide resistance mediated by enterococcal transposon Tn 1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol. Microbiol. 13:1065-1070. http://dx.doi.org/10.1111/j.1365-2958.1994.tb00497.x.